Pediatric high-risk tumors: gene defect shortens survival and needs targeted treatment

Pediatric high-risk tumors: gene defect shortens survival and needs targeted treatment

(Vienna, 11.06.2021) Neuroblastomas, the most common solid tumors outside the brain in children, are associated with poorer survival if they have genetic alterations in the ALK gene and belong to the high-risk group. This was shown by scientists from St. Anna Children's Cancer Research institute together with colleagues in an…